Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective neck dissection (I-III) for node negative and node positive necks.

Kumar Alok Pathak1, Ashok K Das, Ritu Agarwal

  • 1Head and Neck Service, Department of Surgery, Tata Memorial Hospital, Dr. E. Borges Road, Parel, Mumbai 400 012, India. kapathak@rediffmail.com

Oral Oncology
|May 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Use of Radioiodine Therapy in Differentiated Thyroid Carcinoma: A Population-Based Cohort Study.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Prevention and Treatment of Vitamin D Deficiency in India: An Expert Group Consensus.

Indian journal of endocrinology and metabolism·2025
Same author

Compartmentalization of High Infratemporal Fossa in Oral Cavity Squamous Cell Carcinomas and Its Impact on Clinical Outcome.

Current oncology (Toronto, Ont.)·2025
Same author

Comprehensive review of post-treatment imaging in head and neck cancers: from expected to unexpected and beyond.

The British journal of radiology·2024
Same author

Adjuvant therapy for intermediate risk factors in oral cancer: Can we reach a consensus?

Oral oncology·2024
Same author

Imaging Recommendations for Diagnosis and Management of Primary Parathyroid Pathologies: A Comprehensive Review.

Cancers·2024

Selective neck dissection (levels I-III) provides comparable oral cancer regional control to modified radical neck dissection but with reduced morbidity. Key factors influencing recurrence include tumor dedifferentiation and perineural spread.

Area of Science:

  • Oncology
  • Head and Neck Surgery
  • Surgical Oncology

Background:

  • Oral cancers require effective management of regional lymph node metastasis.
  • Modified radical neck dissection (MRND) is a standard treatment but associated with significant morbidity.
  • Selective neck dissection (SND) aims to reduce morbidity while maintaining oncologic control.

Purpose of the Study:

  • To evaluate the efficacy and safety of selective neck dissection (levels I-III) in oral cancer patients.
  • To compare regional control rates and morbidity between SND and MRND.
  • To identify factors associated with regional failures after SND.

Main Methods:

  • Retrospective analysis of 414 oral cancer patients undergoing SND (levels I-III) between 1994 and 2001.

Related Experiment Videos

  • Assessment of primary tumor characteristics, clinical nodal status, and follow-up data.
  • Analysis of regional failure rates, patterns of recurrence, and associated prognostic factors.

    • Main Results:

    • SND (levels I-III) demonstrated similar regional control rates to MRND with less morbidity.
    • Overall isolated neck failure rates were low (4.8% at 2 years, 5.8% at 5 years).
    • Tumor dedifferentiation and perineural spread were significantly associated with regional failures. Recurrences were predominantly ipsilateral and within the dissected levels.

    Conclusions:

    • Selective neck dissection (levels I-III) is a viable oncologically sound alternative to MRND for select oral cancer patients.
    • Careful patient selection and consideration of prognostic factors are crucial for optimizing outcomes.
    • Further research into tailoring neck dissection extent based on tumor biology is warranted.